Damage-Associated Molecular Patterns in Inflammatory Diseases

被引:702
作者
Roh, Jong Seong [1 ]
Sohn, Dong Hyun [1 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, 49 Busandaehak Ro, Yangsan 50612, South Korea
关键词
Damage-associated molecular patterns; Inflammation; Pattern recognition receptors; Inflammatory diseases; TOLL-LIKE RECEPTOR; SMOOTH-MUSCLE-CELLS; RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; HMGB1; EXPRESSION; LUPUS NEPHRITIS; SYNOVIAL-FLUID; SERUM-LEVELS; DANGER; ATHEROSCLEROSIS;
D O I
10.4110/in.2018.18.e27
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules that are released from damaged or dying cells and activate the innate immune system by interacting with pattern recognition receptors (PRRs). Although DAMPs contribute to the host's defense, they promote pathological inflammatory responses. Recent studies have suggested that various DAMPs, such as high-mobility group box 1 (HMGB1), S100 proteins, and heat shock proteins (HSPs), are increased and considered to have a pathogenic role in inflammatory diseases. Here, we review current research on the role of DAMPs in inflammatory diseases, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, atherosclerosis, Alzheimer's disease, Parkinson's disease, and cancer. We also discuss the possibility of DAMPs as biomarkers and therapeutic targets for these diseases.
引用
收藏
页数:14
相关论文
共 92 条
  • [21] Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
    Ghiringhelli, Francois
    Apetoh, Lionel
    Tesniere, Antoine
    Aymeric, Laetitia
    Ma, Yuting
    Ortiz, Carla
    Vermaelen, Karim
    Panaretakis, Theocharis
    Mignot, Gregoire
    Ullrich, Evelyn
    Perfettini, Jean-Luc
    Schlemmer, Frederic
    Tasdemir, Ezgi
    Uhl, Martin
    Genin, Pierre
    Civas, Ahmet
    Ryffel, Bernhard
    Kanellopoulos, Jean
    Tschopp, Juerg
    Andre, Fabrice
    Lidereau, Rosette
    McLaughlin, Nicole M.
    Haynes, Nicole M.
    Smyth, Mark J.
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. NATURE MEDICINE, 2009, 15 (10) : 1170 - U99
  • [22] Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis
    Goldstein, Richard S.
    Bruchfeld, Annette
    Yang, Lihong
    Qureshi, Abdul R.
    Gallowitsch-Puerta, Margot
    Patel, Nirav B.
    Huston, Brett J.
    Chavan, Sangeeta
    Rosas-Ballina, Mauricio
    Gregersen, Peter K.
    Czura, Christopher J.
    Sloan, Richard P.
    Sama, Andrew E.
    Tracey, Kevin J.
    [J]. MOLECULAR MEDICINE, 2007, 13 (3-4) : 210 - 215
  • [23] Immunity, Inflammation, and Cancer
    Grivennikov, Sergei I.
    Greten, Florian R.
    Karin, Michael
    [J]. CELL, 2010, 140 (06) : 883 - 899
  • [24] Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
    Hansson, GK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) : 1685 - 1695
  • [25] The immune system in atherosclerosis
    Hansson, Goran K.
    Hermansson, Andreas
    [J]. NATURE IMMUNOLOGY, 2011, 12 (03) : 204 - 212
  • [26] Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice
    Harja, Evis
    Bu, De-Xiu
    Hudson, Barry I.
    Chang, Jong Sun
    Shen, Xiaoping
    Hallam, Kellie
    Kalea, Anastasia Z.
    Lu, Yan
    Rosario, Rosa H.
    Oruganti, Sai
    Nikolla, Zana
    Belov, Dmitri
    Lalla, Evanthia
    Ramasamy, Ravichandran
    Yan, Shi Fang
    Schmidt, Ann Marie
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) : 183 - 194
  • [27] Heat shock protein 90 maintains the tumour-like character of rheumatoid synovial cells by stabilizing integrin-linked kinase, extracellular signal-regulated kinase and protein kinase B
    Hashiramoto, Akira
    Murata, Miki
    Kawazoe, Takako
    Yoshida, Kohsuke
    Akiyama, Chieri
    Shiozawa, Kazuko
    Shiozawa, Shunichi
    [J]. RHEUMATOLOGY, 2011, 50 (05) : 852 - 861
  • [28] A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
    Haybaeck, Johannes
    Zeller, Nicolas
    Wolf, Monika Julia
    Weber, Achim
    Wagner, Ulrich
    Kurrer, Michael Odo
    Bremer, Juliane
    Iezzi, Giandomenica
    Graf, Rolf
    Clavien, Pierre-Alain
    Thimme, Robert
    Blum, Hubert
    Nedospasov, Sergei A.
    Zatloukal, Kurt
    Ramzan, Muhammad
    Ciesek, Sandra
    Pietschmann, Thomas
    Marche, Patrice N.
    Karin, Michael
    Kopf, Manfred
    Browning, Jeffrey L.
    Aguzzi, Adriano
    Heikenwalder, Mathias
    [J]. CANCER CELL, 2009, 16 (04) : 295 - 308
  • [29] Heat shock protein antagonists in early stage clinical trials for NSCLC
    Hendriks, Lizza E. L.
    Dingemans, Anne-Marie C.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 541 - 550
  • [30] Damage-associated molecular patterns in cancer: a double-edged sword
    Hernandez, C.
    Huebener, P.
    Schwabe, R. F.
    [J]. ONCOGENE, 2016, 35 (46) : 5931 - 5941